Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

42 results about "Zinc protoporphyrin" patented technology

Zinc protoporphyrin (ZPP) is a compound found in red blood cells when heme production is inhibited by lead and/or by lack of iron. Instead of incorporating a ferrous ion, to form heme, protoporphyrin IX, the immediate precursor of heme, incorporates a zinc ion, forming ZPP. The reaction to insert a ferrous ion into protoporphyrin IX is catalyzed by the enzyme ferrochelatase.

Zinc protoporphyrin containing heterocyclic ring as well as synthesis and applications of zinc protoporphyrin containing heterocyclic ring and metal complex of zinc protoporphyrin containing heterocyclic ring

The invention provides a zinc protoporphyrin containing a heterocyclic ring as well as the synthesis and the applications of the zinc protoporphyrin containing a heterocyclic ring and a metal complex of the zinc protoporphyrin containing a heterocyclic ring, belonging to the technical field of solar cell applications. In the zinc protoporphyrin containing a heterocyclic ring, benzaldehyde, a derivant of benzaldehyde and pyrrole serve as raw materials, multiple steps of reactions, such as condensation, coordination, substitution and the like are carried out, and a zinc protoporphyrin monomer molecule containing a heterocyclic ring substituted group and a metal complex of the zinc protoporphyrin monomer molecule containing a heterocyclic ring substituted group are successfully synthesized. The photoelectric property research on the zinc protoporphyrin containing a heterocyclic ring and the metal complex of the zinc protoporphyrin containing a heterocyclic ring in preparing the sensitization crystal TiO2 solar cell shows that the zinc protoporphyrin containing a heterocyclic ring and the metal complex of the zinc protoporphyrin containing a heterocyclic ring have good application prospects in the sensitization solar cell.
Owner:NORTHWEST NORMAL UNIVERSITY

Bismuth sulfide-zinc protoporphyrin composite material with tumor photodynamic therapy property under excitation of near-infrared light as well as preparation method and application

The invention relates to a bismuth sulfide-zinc protoporphyrin composite material with a tumor photodynamic therapy (PDT) property under excitation of near-infrared light as well as a preparation method and application and belongs to the field of composite materials, aiming at solving the problem that the PDT efficiency is relatively low, caused by photoelectron-hole compounding in a photodynamictherapy process of bismuth sulfide and an anti-oxidization stress capability of heme oxygenase (HO-1) in cells. The composite material is the bismuth sulfide-zinc protoporphyrin composite material which is obtained by synthesizing a polyN-isopropylacrylamide-acrylamide copolymer modified bismuth sulfide nano-material and then carrying out condensation reaction of carboxyl and amino. The prepared composite material has the effect of enhancing the photodynamic therapy efficiency through two ways of inhibiting the activity of the heme oxygenase and promoting electron-hole separation; meanwhile, the material provided by the invention has good biocompatibility, light stability, CT (Computed Tomography) imaging capability and enhanced PDT efficiency; a thought is provided for designing a novel nano diagnosis and treatment integrated system and the material has important meaning on early-stage diagnosis and treatment of cancers.
Owner:中科应化(长春)科技有限公司

Method and device for measuring concentration of zinc protoporphyrin substance in blood

The invention discloses a method and device for measuring the concentration of a zinc protoporphyrin substance in blood. The method comprises the steps of: irradiating a sample to be measured by an excitation light source, and obtaining the characteristic fluorescence signal of the sample to be measured within a period of time; calculating the characteristic fluorescence intensity data of the sample to be measured based on the characteristic fluorescence signal of the sample to be measured within the period of time; by means of the characteristic fluorescence intensity data and the zinc protoporphyrin concentration data of multiple groups of standard samples, linearly correcting a proportional relation between the characteristic fluorescence intensity data and the zinc protoporphyrin concentration to obtain a proportional line segment correction curve; and calculating the zinc protoporphyrin concentration of the sample to be measured according to the characteristic fluorescence intensity data of the sample to be measured and the proportional line segment correction curve. The device using the method can reduce the error of data acquisition, eliminates systematic errors including a zero point error and an optical error, and improves the stability and accuracy of blood zinc proporphyrin substance concentration measurement results.
Owner:深圳市申一科技有限公司

Bismuth sulfide-zinc protoporphyrin composite material with tumor photodynamic therapy properties under near-infrared light excitation and its preparation method and application

The invention relates to a bismuth sulfide-zinc protoporphyrin composite material with a tumor photodynamic therapy (PDT) property under excitation of near-infrared light as well as a preparation method and application and belongs to the field of composite materials, aiming at solving the problem that the PDT efficiency is relatively low, caused by photoelectron-hole compounding in a photodynamictherapy process of bismuth sulfide and an anti-oxidization stress capability of heme oxygenase (HO-1) in cells. The composite material is the bismuth sulfide-zinc protoporphyrin composite material which is obtained by synthesizing a polyN-isopropylacrylamide-acrylamide copolymer modified bismuth sulfide nano-material and then carrying out condensation reaction of carboxyl and amino. The prepared composite material has the effect of enhancing the photodynamic therapy efficiency through two ways of inhibiting the activity of the heme oxygenase and promoting electron-hole separation; meanwhile, the material provided by the invention has good biocompatibility, light stability, CT (Computed Tomography) imaging capability and enhanced PDT efficiency; a thought is provided for designing a novel nano diagnosis and treatment integrated system and the material has important meaning on early-stage diagnosis and treatment of cancers.
Owner:中科应化(长春)科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products